It’s a rare type of hypertension associated with one of the most severe organ complications affecting around 15-501 in one million people among the general population. But among patients with systemic scleroderma (SSc), pulmonary arterial hypertension (PAH) remains the major cause of death, with the debilitating condition affecting as many as 1 in 102 patients. ...
Room for improvement in the management of scleroderma associated PAH
By Sunalie Silva
10 Feb 2017
Sponsored by Actelion Pharmaceuticals